Speakers from Touchstone Exploration, Shanta Gold, Savannah Resources and Kavango Resources feature in our Natural Resources webinar on May 25th. Please register here.

Less Ads, More Data, More Tools Register for FREE

EU seals supply deal with Johnson & Johnson on COVID-19 vaccine

Thu, 8th Oct 2020 11:06

BRUSSELS, Oct 8 (Reuters) - The European Commission said on
Thursday it had sealed a supply deal with Johnson & Johnson
for the supply of its potential COVID-19 vaccine for up
to 400 million people.

This is the third advance purchase contract signed by the EU
with makers of COVID-19 vaccines after deals with AstraZeneca
and Sanofi.
(Reporting by Francesco Guarascio; editing by Jason Neely
@fraguarascio)

Related Shares

More News

UK to give under 40s alternative to AstraZeneca vaccine

(Sharecast News) - The UK government decided on Friday to offer people under 40 an alternative to the AstraZeneca Covid-19 vaccine, reported Bloomberg.

Today 09:49

All under-40s to be offered alternative to AstraZeneca vaccine

All under-40s to be offered alternative to AstraZeneca vaccine

Today 08:49

AstraZeneca reports positive results in Phase 3 lung cancer drug trial

AstraZeneca reports positive results in Phase 3 lung cancer drug trial

Today 08:32

AstraZeneca's Imfinzi demonstrates benefit in combination with antibody

(Sharecast News) - AstraZeneca reported on Friday that 'Imfinzi' and tremelimumab with chemotherapy demonstrated an overall survival benefit in the 'POSEIDON' trial for first-line stage four non-small cell lung cancer, making it the first phase 3 trial to demonstrate an overall survival benefit with tremelimumab.

Today 07:42

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.